Pulmonary Arterial Hypertension Market Size, Share & Trends Analysis Report By Drug Class, By Type (Branded, Generics), By Route of Administration (Oral, Intravenous/ subcutaneous, Inhalational), By Region, And Segment Forecasts, 2022 - 2030
Market Overview
Fatpos Global has released a report titled Pulmonary Arterial Hypertension Market - Analysis of Market Size, Share & Trends for 2014 - 2020 and Forecasts to 2031. According to a study by Fatpos Global, is anticipated to reach at USD 7.0 billion in 2021 and is estimated to expand at a compound annual growth rate (CAGR) of 5.2% from 2022 to 2030.
According to the report, emphasizes on the detailed understanding of some decisive factors such as size, share, sales, forecast trends, supply, production, demands, industry and CAGR in order to provide a comprehensive outlook of the global market
Pulmonary Arterial Hypertension Market Market: Key Players
United Therapeutics Corporation
Bayer
Gilead Sciences, Inc.
Johnson & Johnson
Viatris Inc.
GlaxoSmithKline
Sandoz Inc. (Novartis)
Lupin Pharmaceuticals, Inc.
Sun Pharmaceutical Industries, Inc.
Teva Pharmaceutical Industries Ltd.
Segmentation
Research has segmented the global pulmonary arterial hypertension market report on the basis of drug class, type, route of administration, and region:
Drug Class Outlook (Revenue, USD Million, 2017 - 2030)
Endothelin Receptor Antagonists (ERAs)
PDE-5 Inhibitors
Prostacyclin and Prostacyclin Analogs
SGC Stimulators
Type Outlook (Revenue, USD Million, 2017 - 2030)
Branded
Generics
Route of Administration Outlook (Revenue, USD Million, 2017 - 2030)
Oral
Intravenous/ subcutaneous
Inhalational
Pulmonary Arterial Hypertension Market Market Dynamics
Pulmonary Arterial Hypertension Market Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
COVID-19 pre and post business impact analysis
Detailed overview of the parent market
Changing market dynamics in the industry
In-depth market segmentation
What is the Pulmonary Arterial Hypertension Market Market growth?
Which segment accounted for the largest Pulmonary Arterial Hypertension Market Market share?
Who are the key players in the Griddles Market?
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint
Note: Although care has been taken to maintain the highest levels of accuracy in Fatpos Global’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
*Please Note: The report will be delivered in 4-5 business days upon order confirmation*
- 1. Executive Summary
- 2. Pulmonary Arterial Hypertension Market
- 2.1. Product Overview
- 2.2. Market Definition
- 2.3. Segmentation
- 2.4. Assumptions and Acronyms
- 3. Research Methodology
- 3.1. Research Objectives
- 3.2. Primary Research
- 3.3. Secondary Research
- 3.4. Forecast Model
- 3.5. Market Size Estimation
- 4. Average Pricing Analysis
- 5. Macro-Economic Indicators
- 6. Market Dynamics
- 6.1. Growth Drivers
- 6.2. Restraints
- 6.3. Opportunity
- 6.4. Trends
- 7. Correlation & Regression Analysis
- 7.1. Correlation Matrix
- 7.2. Regression Matrix
- 8. Recent Development, Policies & Regulatory Landscape
- 9. Risk Analysis
- 9.1. Demand Risk Analysis
- 9.2. Supply Risk Analysis
- 10. Pulmonary Arterial Hypertension Market Analysis
- 10.1. Porters Five Forces
- 10.1.1. Threat of New Entrants
- 10.1.2. Bargaining Power of Suppliers
- 10.1.3. Threat of Substitutes
- 10.1.4. Rivalry
- 10.2. PEST Analysis
- 10.2.1. Political
- 10.2.2. Economic
- 10.2.3. Social
- 10.2.4. Technological
- 11. Pulmonary Arterial Hypertension Market
- 11.1. Market Size & forecast, 2020A-2030F
- 11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12. Pulmonary Arterial Hypertension Market: Market Segmentation
- 12.1. By Regions
- 12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.2. By network type: Market Share (2020-2030F)
- 12.2.1. Hardware , By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.2.2. Software , By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.2.3. Services , By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.3. By End user: Market Share (2020-2030F)
- 12.3.1. Manufacturing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.3.2. Healthcare, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.3.3. Energy and Utilities, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.3.4. IT & Telecom, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.3.5. Automotive and Transportation, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.3.6. Supply Chain and Logistics, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.3.7. Government and Public Safety, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.3.8. Agriculture, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.3.9. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- Company Profile
- United Therapeutics Corporation
- Bayer
- Gilead Sciences, Inc.
- Johnson & Johnson
- Viatris Inc.
- GlaxoSmithKline
- Sandoz Inc. (Novartis)
- Lupin Pharmaceuticals, Inc.
- Sun Pharmaceutical Industries, Inc.
- Teva Pharmaceutical Industries Ltd.
- Consultant Recommendation
- **The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook